Testosterone replacement therapy (TRT) before total knee arthroplasty (TKA) is associated with an increased risk for medical and periprosthetic complications, a ...
Glenmark to launch the first generic version of Flovent HFA, expanding affordable access; achondroplasia treatment granted accelerated approval; Dupixent approved for allergic fungal rhinosinusitis; ...
Odds of prescription rise with increasing age, increasing BMI, abnormal lab testing, non-Hispanic White or Hispanic race, ethnicity ...
Imlifidase is a Streptococcus pyogenes-derived cysteine protease that rapidly degrades immunoglobulin G antibodies within 2 to 6 hours of administration.
Sutacimig is an investigational bispecific antibody designed to bind to endogenous factor VIIa and localize it to activated platelets, thereby promoting thrombin and fibrin formation.
Though the decision on elimination status has been postponed, the timeline to be considered is unchanged. Officials will determine whether transmission continues for a full year after the start of the ...
School-based cohort had lower risk for cervical cancer compared with the opportunistic cohort after adjustment for covariates.
Collagen supplementation consistently associated with favorable outcomes for skin, musculoskeletal health, osteoarthritis conditions.
HealthDay News — Among young adults, first ST-segment elevation myocardial infarction (STEMI) in-hospital mortality increased from 2011 to 2022, according to a study published online February 26 in ...
No significant improvement seen in overall survival with addition of hormone therapy to post-radical prostatectomy radiotherapy.
AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.
HealthDay News — Daily aspirin use does not offer a reliable way to prevent colorectal cancer (CRC), according to a review published online February 26 in the Cochrane Database of Systematic Reviews.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results